EGFR essential for the development of pancreatic cancer

	Tweet

The epidermal growth factor receptor (EGFR) gene is essential for KRAS-driven pancreatic cancer development, according to study results presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, held here Sept. 14-18, 2011.

The mutation of the KRAS gene has been found to be an important component in the development of many cancers, including pancreatic cancer. However, Barbara M. Gruener, researcher at the Technical University in Munich, Germany, said that despite the presence of KRAS, the development of preneoplastic precursor lesions and pancreatic ductal adenocarcinoma is blocked without the EGF receptor.

“These results revealed an unappreciated central role of EGFR very early in the carcinogenic process,” said Gruener, who is a doctoral student at the university.

Gruener and colleagues compared more than 40 mice with the pancreas-specific deletion of EGFR with the KRAS mouse model for pancreatic cancer. 

"Contrary to current opinion, we showed that lack of EGFR blocks the development of pancreatic cancer,” she said. “Originally, we wanted to characterize the known role of EGFR in pancreatic cancer to a higher extent so that EGFR targeted therapy could be more individualized.”

Gruener said the results were not what researchers had expected and were surprising.

“With oncogenic active KRAS, you would expect that the lack of a receptor that is upstream of the KRAS signaling pathway does not impair the carcinogenic effects of KRAS almost completely,” she said.

###

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes seven major peer-reviewed journals: Cancer Discovery; Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Prevention Research. AACR journals received 20 percent of the total number of citations given to oncology journals in 2010.

###

Contact: Jeremy Moore

267-646-0557
American Association for Cancer Research

RELATED STORIES:
Mayo Clinic Researchers Find Oncogene is Important in Pancreatic Cancer Growth and Spread   Pancreatic cancer and ecoendoscop   First Use of Innovative “IRE” on Pancreatic Tumor   Protein found to regulate spread of pancreatic cancer cells   UNC team discovers promising target for new pancreatic cancer treatments   MD Anderson Orlando Moves Pancreatic Cancer Research Forward   Herbal remedy shown to have anti-cancer effect   Shining light on pancreatic cancer   Researchers ID Gene Involved in Pancreatic Cancer   Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others   New treatment combination safe for pancreatic cancer patients   The protein survivin could be a useful biomarker for pancreatic cancer   Burned meat linked to pancreatic cancer   Nanoscopic changes to pancreatic cells reveal cancer   Gefitinib may have chemopreventive benefits in pancreatic cancer   Pancreatic Cancer Expert at University of Virginia   Penn researchers uncover novel immune therapy for pancreatic cancer   Islet Cell Tumors (Endocrine Pancreas)   November is Pancreatic Cancer Awareness Month   Pancreatic cancer risk varies with smoking habits   Possible origins of pancreatic cancer revealed   New research improves early detection and survival for pancreatic cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]